GSK

FDA approves hepatitis B drug that lets some patients stop pills

Hibsago, an antisense injection from GSK, gave about one in five eligible adults a functional cure in two phase 3 trials, against none on placebo.

20 October 2026

Illustration of the large bowel and rectum with a tumour growing in the bowel wall

Drug Approvals

FDA approves immunotherapy that can spare rectal cancer surgery

Jemperli won accelerated approval for dMMR or MSI-H stage II and III rectal cancer after most AZUR-1 patients needed no chemotherapy, radiotherapy or surgery.

19 October 2026